Julian Baker’s Tango Therapeutics TNGX Stock Holding History

Julian Baker’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4M	Buy	+333,333	New	+$8.24M	0.05%	68
2024 Q4	–	Sell	-750,000	Closed	-$5.78M	–	102
2024 Q3	$5.78M	Hold	750,000	–	–	0.06%	63
2024 Q2	$6.43M	Hold	750,000	–	–	0.08%	57
2024 Q1	$5.96M	Hold	750,000	–	–	0.07%	60
2023 Q4	$7.42M	Hold	750,000	–	–	0.08%	57
2023 Q3	$8.45M	Hold	750,000	–	–	0.05%	49
2023 Q2	$2.49M	Hold	750,000	–	–	0.01%	89
2023 Q1	$2.96M	Hold	750,000	–	–	0.02%	82
2022 Q4	$5.44M	Hold	750,000	–	–	0.03%	77
2022 Q3	$2.71M	Hold	750,000	–	–	0.02%	95
2022 Q2	$3.4M	Hold	750,000	–	–	0.02%	87
2022 Q1	$5.68M	Hold	750,000	–	–	0.03%	82
2021 Q4	$8.21M	Hold	750,000	–	–	0.04%	81
2021 Q3	$9.7M	Buy	+750,000	New	+$8.99M	0.04%	78

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Julian Baker's TNGX Position: Q2 2026 in Review

Julian Baker opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 333,333 shares worth $10.4M. The stake represents 0.05% of the portfolio and ranks #68 among its holdings. This is a return to the name: Julian Baker previously reported a position in TNGX as recently as Q3 2024.

Julian Baker first reported a position in TNGX in Q3 2021 and has held it in 14 quarters since. 246 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Julian Baker held 333,333 shares of Tango Therapeutics worth $10.4M as of Q2 2026.
Tango Therapeutics was a new Julian Baker position in Q2 2026.
Tango Therapeutics made up 0.05% of Julian Baker's portfolio in Q2 2026, its #68 holding.
Julian Baker first reported a position in Tango Therapeutics in Q3 2021 and has held it in 14 quarters since.
246 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.